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THE EFFECT OF NUTRITIONAL SUPPLEMENTATION AND
EXERCISE ON SUBJECTIVE PAIN AND FUNCTION IN
PEOPLE WITH OSTEOARTHRITIS OF THE KNEE
ABSTRACT

Nutritional Supplementation of glucosamine sulfate and chondroitin sulfate are being
promoted in the treatment o f osteoarthritis. Recent research has indicated that gelatin was
found effective. Moderate exercise is also being advocated. The purpose o f this eight
week double blind study was to examine the effects o f the inexpensive nutritional
supplement gelatin, in the form o f Knox Nutrajoint, and exercise on pain and functional
activity in 49 subjects with osteoarthritis in one or both knees. Subjects were randomly
assigned to one o f four groups: placebo, placebo plus exercise, gelatin supplement plus
exercise and exercise. Exercise consisted o f a progressive walking program. Results
were assessed via ANOVA and ANCOVA. No significant difference (p<.05) was found
for any group on perceived functional ability or pain as measured by the Arthritis Index
Measurement Tool. Both exercise groups did show a significant improvement in mood
level. The result o f this study could not support the use o f gelatin supplementation or a
non supervised walking program for the treatment o f OA.
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CHAPTER 1
INTRODUCTION
Background to Problem

Osteoarthritis (OA) is a major cause o f disabilities among the aging
population in the United States. This disease is not only painful but also has a
significant impact on function and quality o f life.
As one ages, there are several changes in the body that have an effect on
joints. There is a reduction in the number o f chondrocytes in cartilage. Cartilage
is broken down at a faster rate than it is being formed (Heft, 1995). Increased age
is also correlated with decreased absorption o f dietary nutrients (Heuther, 1994).
Therefore, people may not be absorbing enough of the required nutrients to
maintain healthy cartilage even if their diet has not changed. Also, the level of
activity tends to decrease quite significantly in many individuals as they get older.
Decreased physical activity has a negative effect on joint cartilage secondary to
the decrease in nutritional exchange (Hallet, 1994).
Many researchers have correlated moderate exercise programs with
increased function and reduced pain in people with OA (Fisher, 1993, Schilke,
1996, Minor, 1989, Ettinger, 1997). Exercise increases general circulation in the
body. It increases the metabolic rate o f the involved tissues which promotes a
stronger, healthier tissue and an increased healing rate after injury (Simkin, 1990).

Intermittent compression and decompression along with gliding of articular
cartilage during moderate exercise activities allows synovial fluid to nourish the
joint and remove waste products (Hallet, 1994). This movement can also lead to
thickening and increased resilience in the cartilage. Exercise also leads to
increased muscle and ligamentous strength that provides stability to the joint
(Altman, 1990).
Context and Background to Problem
Research is accumulating that dietary supplements such as Glucosamine
sulfate and chondroitin sulfate (Tapadinhas, 1982, Drovanti, 1980, Vas, 1982,
D’Ambrosio, 1981), Vitamin C (Kipp, 1996, New, 1997, McAlindon, 1996a) and
Calcium (New, 1997, McAlindon, 1996b) may decrease pain, improve function
and even promote regeneration o f articular cartilage. A recently published book.
The Arthritis Cure (1997) examines the benefits o f glucosamine sulfate and
chondroitin sulfate. This has lead to a surge in sales o f these non-prescription
nutritional supplements. However, these supplements can be expensive and often
fail to contain the listed "amount o f ingredient” (Schardt, 1998). There is another
nutritional supplement, gelatin, that contains the basic amino acid components of
cartilage, it is cheaper and consistently high in quality.
Gelatin hydrosylate, a dietary supplement, is composed of glycine, proline,
and other amino acids. These are the components for the biochemical matrix of
human cartilage. In a double-blinded study by Adam (1991) 10 grams o f gelatin
hydrosylate was administered to 52 patients with a diagnosis o f OA. All patients
were given the gelatin for a period o f 2 months. The results indicated a significant

decrease in subjective pain as well as a decrease in the amount o f analgesics that
were consumed. There was no reported change in the patients that received a
placebo.
The Nabisco Company produces a gelatin product called Nutrajoint® that
claims to maintain joint and bone health. Knox Nutrajoint® contains gelatin
hydrosylate, 100% o f RDA for Vitamin C, and 15% o f RDA for Calcium. This
nutritional supplement is sold in powder form and can easily be dissolved into a
beverage for consumption.
In addition to nutritional supplementation, exercise has also been shown to
have a positive effect on joint health. Recent research regarding the treatment of
OA has focused on increasing the strength o f the knee musculature with resistance
exercises and/or aerobic exercise programs (Ettinger, 1997, Schilke, 1996, Hallet,
1994, Fisher, 1993, Minor, 1989). Since most individuals are not aware of the
appropriate exercise programs, referral to Physical Therapy is becoming an
important treatment approach to reduce pain and increase function in people with
OA.
Problem Statement
Increasing numbers o f people are being referred to physical therapy for
treatment of OA. However, the number of treatment visits that insurance will
cover for each patient is decreasing. Studies have shown that moderate exercise
creates the proper conditions for cartilage to regenerate. However, excessive
exercise can cause the degeneration o f cartilage (Hallet, 1994). Other studies

have shown that nutritional supplementation can decrease pain and increase
function in patients with OA. Conversely, a lack o f exercise and or proper
nutrition can cause a degeneration o f articular cartilage (McDonough, 1981).
There are no known studies that compare the effects o f exercise and nutritional
supplementation. There are only two studies that have looked at the effects o f
supplementation with gelatin hydrosylate on OA (Adams, 1995, Oberschelp,
1985).
Aims and Purpose
The purpose o f this study was to compare the effects o f a placebo
supplement to 1) exercise alone, 2) a nutritional supplementation o f Knox
Nutrajoint® (which contains gelatin hydrosylate. Vitamin C, and Calcium), and
3) a nutritional supplementation o f Knox Nutrajoint in combination with exercise
in the reduction o f pain and subjective increase o f function in patients with OA o f
the knee.
Hvnothesis/Research Question
The first hypothesis was that nutritional supplementation o f Knox
Nutrajoint® in combination with a moderate exercise program will be superior to
the effects o f either exercise alone or Knox Nutrajoint alone when compared to a
placebo supplement in the reduction o f pain and subjective increase in function in
subjects with OA of the knee(s).

The second hypothesis was that the treatment groups receiving nutritional
supplementation or exercise would report greater relief o f symptoms than the
group receiving only a placebo.
Significance o f Problem

In light of recent changes within health care regarding finance and time
constraints, it is integral that physical therapists research the most efficient and
cost effective treatments. If researchers can demonstrate that an inexpensive
nutritional supplementation in combination with exercise is superior to exercise
alone or nutritional supplementation alone in relieving pain and dysfunction
caused by OA then it is in the patient’s best interest and that o f the Physical
Therapy profession to study and promote such discoveries. Not only can this
have an effect on the efficacy o f treatment but it can also reduce the number of
Physical Therapy treatments. This could reduce the overall cost o f treatment and
improve the quality of life for people suffering from OA. Ultimately there could
be a reduction in the number o f joint replacements for OA sufferers which would
save time and money for patients, and third party payers, in addition to reducing
unnecessary pain and dysfunction that patients must endure.

CHAPTER 2
LITERATURE AND CONCEPTUAL FRAMEW ORK
Introduction
In the last several years there has been much research done on the cause,
management and prevention of Osteoarthritis. Recently there has been a push
towards the use o f nutrition or nutritional supplements in the management and
prevention of OA. This chapter will review the pertinent literature related to
articular cartilage structure, age-related changes with articular cartilage, the
pathology of Osteoarthritis and current treatments for this disease.
Conceptual Framework
The Matrix of Hyaline Cartilage
Hyaline cartilage covers the surface o f bones that form synovial joints. A
synovial joint is one in which the articulating bones are covered with hyaline
cartilage and are joined together with ligaments and a capsule lined by a synovial
membrane that secretes a lubricant into the joint. The hyaline cartilage allows for
a smooth low friction surface for the articulation between bones. The cartilage is
composed of a large extracellular matrix that includes both fibrous and nonfibrous
components as well as a relatively small cellular component. The fibrous
component of the extracellular matrix is made of elastin and types 11, IX, and XI
collagens (Jimenez, 1988). Collagen fibers are composed o f the amino acids
proline, lysine and glycine. These fibrous components provide support and
elasticity to the matrix. The non-fibrous component of the extracellular matrix is

made o f glycoproteins and proteoglycans consisting o f dennatin sulfate,
chondroitin 4 and 6 sulfate and hyaluronic acid. The glycoproteins and
proteoglycans attract water and chains o f glycosaminoglycans which hydrate the
cartilage and provide support for the cellular components (Walker, 1996).
Hyaline cartilage is avascular and aneural. It relies heavily on synovial
fluid to provide nutrition and remove waste products. As the joint moves the
compressive force that develops between joint surfaces pushes the fluid out o f the
cartilage into the joint space. When the compressive forces are removed the fluid
is reabsorbed into the cartilage. Joint sliding which occurs during joint movement
may help distribute the synovial fluid and improve its penetration into the
cartilage. During immobilization o f a joint the synovial fluid can not adequately
nourish cartilage (McDonough, 1981). Thus, a joint must function and move in
order to prevent degeneration.
Review o f Literature
Pathophysiology of OA
Osteoarthritis is a progressive degenerative disease that slowly destroys
the articular cartilage and adjacent periosteal bone in weight bearing joints and
frequently used upper extremity joints. Adam (1995) stated that 90% of the
population is affected by Osteoarthritis by the age o f 70 years. With aging there is
a significant loss in the amount o f proteoglycan within articular cartilage. This
makes the cartilage less smooth and more susceptible to erosion and deformation,
decreasing the shock absorption capabilities. The loss o f the proteoglycans also
decreases the ability of the cartilage to absorb the nutrient rich synovial fluid. As

the connective tissue matrix continues to weaken the cartilage surface becomes
irregular and rough. This causes tiny bits o f cartilage to break off and settle in the
gravity side o f the joint and cause irritation to the capsular lining. Formation of
new type II hyaline collagen is impaired by the aging process due to the altered
activity o f the chondrocytes. Chondrocytes instead begin synthesizing type I and
type n i collagens. The replacement type I and III collagens are fibrous in nature
and do not displace and absorb the forces in the joint the same as the normal type
II collagen. This change in fiber composition has a significant effect on the
biomechanical properties o f the joint. Due to the abnormal stresses and the
formation o f osteophytes around the joint margin, which stretch the joint capsule,
the synovial membrane can become inflamed and get increasingly painful over
time. As the disease progresses, the articular cartilage can erode down to the
periosteum and cause bony changes and deformation.
The number of type II muscle fibers, phasic muscle fibers, also decrease
with aging. This causes a decrease in muscle strength around joints. Proper
muscular and ligamentous support around a joint can minimize the stresses that
are placed on the articular cartilage. The loss o f muscle mass due to either disuse
or aging further increases the stress on weight bearing joints leading to further
progression of OA (Semble, 1990).
Why OA Causes Pain
Several mechanisms have been identified as causes o f pain in OA. No
nocioceptors (pain receptors) have been found in cartilage. Therefore, the pain
that people with OA experience originates firom other sources. The surrounding

ligamentous capsule and synovial lining are highly vascularized and innervated.
If fragments of cartilage are shed on to synovium they can trigger an
inflammatory response in the joint capsule. The increased pressure and
inflammation will stretch the capsule and result in painful symptoms. Crystals of
calcium pyrophosphate dihydrate and calcium hydroxyapatite shed from deeper
articular cartilage can also cause an inflammatory response. Enzymes involved in
the degradation of cartilage are often present in excess in people with OA and
may also stimulate inflam m ation. Destruction of articular cartilage may allow
subchondral bone to become exposed leading to ischemic pain or pain from
increased vascular pressure. Muscle spasm, which is common with OA can also
cause pain, especially in the low back (Altman, 1990). Muscle atrophy, caused by
disuse leads to decreased joint stability, increased biomechanical stress on the
joint and therefore a further progression of OA (Altman, 1990, Marks, 1993).
Current treatment o f Osteoarthritis
Many interventions and coping strategies are used in the treatment of the
progressive disease of Osteoarthritis. These treatments include prevention,
symptom reduction, and strategies to halt or even reverse the damage to the joint.
The load that is put on the weight bearing joints plays an important role in
the development of OA. Depending on the activity, the hip and knee can absorb
forces 3 to 5 times a person's body weight (Walker, 1996). Increased compressive
force on the articular cartilage o f the knees due to increased body weight has been
implicated as a cause o f Osteoarthritis (Felson, 1997). Felson also claims that a

weight loss of 10 pounds is correlated with a decrease in 50% o f the Osteoarthritis
symptoms felt in the knee.
Not only can increased loads predispose a joint to Osteoarthritis but
excessive repetitive activity and/or abnormal stresses due to improper body
mechanics can also accelerate the degeneration o f articular cartilage. Incorrect
body alignment such as pronated feet, genu varum, and genu valgum create
excessive forces on the knee and can cause or aggravate Osteoarthritis (Brandt,
1997). Many o f these mal-alignments can be managed with orthotics.
The emotional and psychological coping mechanisms involved in dealing
with this disease can influence a person's subjective rating o f pain. Because this
disease is not necessarily visible, people may not receive much support from
family and friends for the perceived physical pain caused by OA. Psychosocial
support has been linked with decreased symptoms o f OA. Rene (1982)
discovered that if patients with OA of the knee received a phone call from a
trained "layperson" once a month, there was a significant decrease in pain in the
knee, regardless o f their stable medical regime.
The use of non-steroidal anti-infiammatory agents (NSAIDS), or
analgesics for the symptom management o f patients with OA is very common.
One problem with using NSAIDS for symptom management in OA is the
potential for serious side effects with long term use. For example NSAID use is
associated with increased risk o f gastrointestinal complaints, such as ulceration or
hemorrhage, with increased age. This is significant because the majority o f
people with OA are the elderly (Brandt, 1997).
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Recent studies have also examined potential negative effects on cartilage
with long-term NSAID use. The use o f NSAIDs for 24 hours significantly
decreases the activity o f prolidase and inhibits collagen biosynthesis in vitro
(Miltyk, Kama and Patka, 1996). Prolidase is an enzyme that has a crucial role in
recycling proline for collagen biosynthesis. However, it is questionable if in vitro
results can be generalized to a patient population. Newman and Ling (1985)
concluded that long term use of NSAIDs actually accelerates the joint destruction
in humans. This study, however, was retrospective and therefore also
questionable. The current research suggesting that NSAIDs may be harmful to
cartilage, despite their temporary analgesic effects, does not appear conclusive.
Intra-articular corticosteroid injections are another method used to
decrease pain in Osteoarthritic joints. Hollander (1953) foimd that 87% of 231
patients had decreased pain in the knee after these injections. Hollander
operationally defined a successful injection as one in which the patient had relief
o f pain for a minimum of three days. Although the pain is temporarily relieved,
other problems occur with excessive use o f this therapy. Corticosteroids have
been linked with the break down o f c o lle e n and can lead to joint failure, such as
tendon rupture, with frequent injections (Gray, 1983). In light o f this, Hollander
(1953) suggests that when this management tool is utilized the injections should
be spaced 4 to 6 months apart. Brandt (1997) stated that pain relief after cortisone
injection may only be temporary. He also pointed out that blocking o f the pain
transmission may lead to overuse and further breakdown o f the arthritic joint.

II

In contrast to simply managing pain, treatments have recently emerged
that claim to slow, halt or reverse the process o f cartilage degeneration.
Lequesne, Brandt and Bellamy (1994) demonstrated that the use o f Disease
Modifying Osteoarthritis Drugs (DMOADs) decreased proteolytic cartilage
breakdown and stimulated matrix repair in animals. DMOADs include tissue
extracts firom animals and also site specific coUagenase inhibitors that can attach
to the catalytic site o f the enzyme. Tissue extracts such as glycosaminoglycan
polysulfate, (GAGPS) chondroitin-4-sulfate, and chondroitin-6-sulfate have been
shown to stimulate cartilage synthesis. The use o f these tissue extracts has also
been demonstrated to decrease pain and increase function in patients with OA
(Kerzberg, 1987, Lopes, 1982, Drovati, 1980, Tapadinhas, 1982).
Another type o f DMOAD that has been investigated is gelatin.
Oberschelp (1985) compared three treatments; 1) physical therapy alone, 2)
Gerontamin (gelatin and retinaol acetate) alone, and 3) a combination o f physical
therapy and gelatin in 154 subjects diagnosed with chondromalacia patellae, cox
and gonarthosis, or juvenile spine impairment. Subjects consumed the
supplement daily for three months. He found that both the Gerontamin alone
group and the Gerontamin with physical therapy group had a significant decrease
in pain and an increase in mobility. There were no significant differences
between these groups. The physical therapy alone group had little effect. He
concluded that Gerontamin may be beneficial for people when physical therapy is
not indicated. However, the physical therapy employed in this study involved
only the use of passive modalities such as iontophoresis, electric current.
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hydrotherapy, ultrasound or massage. Current standards o f Physical Therapy for
OA calls for the use of moderate exercise.
In a double blinded study by Adam (1991) 10 grams o f gelatin hydrosylate
was administered to 52 patients with a diagnosis of OA. The subjects were split
in to four groups. Three o f these groups received different forms o f gelatin (10
grams) and the fourth group received a placebo. Subjects were given the
supplements for a period o f 2 months. The results indicated a significant decrease
in subjective pain as well as a decrease in the amount of analgesics that were
consumed among all of the gelatin groups. There was no change in the patients
that received a placebo.
A current product that contains the same components as Gerontamine is
Knox Nutrajoint®. Knox Nutrajoint® claims to contribute to joint health by
providing the nutritional requirements for articular cartilage. The recommended
daily amount o f Knox Nutrajoint® contains 10 grams of hydrosylated gelatin, 60
milligrams of Vitamin C (100% o f RDA), and 300 milligrams o f Calcium (30%
RDA). It comes in powder form which is mixed into a preferred beverage for
consumption.
Physical therapy that combines a balance of strength and aerobic exercise
has been shown to decrease the same amount of symptoms as NSAIDs (Minor,
1989). The rational behind the theory o f exercise and why it can effectively
reduce pain will now be discussed.

Benefits o f Exercise in People with Osteoarthritis.
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In the last decade, there has been a paradigm shift regarding the role that
exercise plays in the management o f Osteoarthritis. Previously, researchers noted
that arthritis sufferers had decreased muscle strength and physical fimess (Minor,
1989). However, the consensus was that exercise would increase the rate of
degeneration of articular cartilage, increasing the likelihood of accelerating the
cartilage degeneration (Bland and Cooper, 1984).
Exercise puts biomechanical and physiological stress on articular cartilage.
There are chondrocytes, which are living cells within the cartilage, that adapt to
the stresses which are imposed on them. These chondrocytes control the
breakdown and build-up of components o f the cartilage matrix. The stress of
static loading on cartilage causes decreased chondrocyte synthesis which leads to
a decrease in the density o f the cartilage. Cartilage motion without compression,
such as passive range of motion, causes thinning o f the articular cartilage.
However, intermittent compression and decompression of cartilage tends to
stimulate chondrocyte growth leading to increased stiffiiess of the cartilage (Hallet
& Andrish, 1994).
In vivo studies, both human and animal, have given researchers insights
regarding the effects o f exercise on cartilage formation and breakdown.
Strenuous levels of exercise tend to cause break down o f articular cartilage. In
vivo canine studies show a 6 to 11% reduction o f Glucosaminoglycogens (GAGS)
after strenuous running for 40 weeks (Hallet and Andrish, 1994). The
Framingham longitudinal study showed that individuals in the highest quartile o f
exercise at baseline where 3.3 times more likely to develop knee Osteoarthritis
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(Felson, 1997). However, studies on humans have not been able to demonstrate a
progression in articular breakdown associated with running (Kujala, 1995, Lane,
1996, Panush, 1986).
Immobilization also leads to decreased articular cartilage and decreased
GAG concentration. In contrast, cyclic loading of articular cartilage increases the
movement of higher molecular weight proteins to the joint. These proteins are
important building blocks o f cartilage (Hallet and Andrish, 1994).
In vivo canine studies with moderate running, 4 km a day for 10 weeks,
showed increased GAG content on femoral condyles, and a 10-28% increase in
thickness of uncalcified cartilage. Hallet and Andrish (1994) concluded that there
may be a critical threshold o f exercise in which too little or too much is
detrimental to articular cartilage.
Minor, et. al.(1989) compared the effects of either aerobic walking,
aerobic aquatic exercise or active range o f motion exercises in 120 patients with
RA or OA. After 12 weeks, a significant gain was found in aerobic capacity and
50 ft. walking time in both the aerobic walking and aerobic aquatic exercise
groups. In addition, these groups also showed decreased depression and anxiety,
and increased physical activity. The aerobic walking and range o f motion groups
reported a significant decrease in pain, however, this was not found with the
aquatic group. Fisher, et al. (1993) were pioneers in their attempt to
quantitatively measure a three month physical therapy intervention in patients
with OA o f the knee. The PT program addressed ROM, muscle strength, pain,
patient education and functional training. Researchers noted that the muscle
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strength and endurance increased significantly in the hamstrings and quadriceps.
Functional gains were made in ability to climb stairs, decreased time to walk 50
ft. and rise from a chair. Subjects also reported less pain with activities o f daily
living.
Recently, a study was conducted by Ettinger, et. al. (1997) to compare the
effectiveness o f the previous treatment interventions o f aerobic exercise and
resistance exercise. Based on a self reported disability and pain questionnaire, the
effects o f structured exercise programs in 365 subjects with OA o f the knee were
analyzed over a period of 18 months. Subjects included males and females age 60
years or older. A control group was used to account for changes related to health
education. Researchers concluded that both aerobic exercise and resisted exercise
interventions were related to a decreased score on disability and knee pain
questionnaire. Also, the time to complete a 6 minute walk test, ascend and
descend stairs, lift and carry 10 pounds and transfer in and out o f a car was
significantly reduced. These effects were reported across sexes and age groups.
Calcium and Vitamin C
Certain levels of Vitamin C, or ascorbic acid, intake may also be important
in the prevention o f Osteoarthritis. In a study using Guinea pigs, decreased
Vitamin C consumption lead to decreased collagen synthesis in articular cartilage
and tendons (Kipp, 1996). In human studies, a 300% reduction in risk of
developing OA was found with both moderate and high consumption of Vitamin
C. This may be because of the antioxidant effects o f the water soluble ascorbic
acid on the Reactive Oxygen Species (ROS) which are generated by chondrocytes
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and neutrophils. These ROS can damage hyaluronan, proteoglycans and collagen
which are important components o f the cartilage matrix. The enzyme used in the
hydroxylation of proline to hydroxyproline requires ascorbic acid in order to be
effective. Collagen that does not contain the hydroxylated proline is less stable,
this is the pathogenesis of connective tissue disorders such as scurvy (Campbell,
1991).
Calcium supplementation has also been implicated in the prevention o f
OA. One theory is that Osteoarthritis is inversely related to bone mineral density
(osteoporosis). As bone loses mineral content and becomes softer it may become
more deformed leading to pain and inflammation. According to McAlindon
(1996b): “the quality of periarticular bone and its capacity to respond to various
stresses, including changes in loading force caused by altered biomechanics, may
influence whether Osteoarthritis stabilizes or progresses.”
It has been well documented that increased calcium supplementation is
correlated with decreased risk o f osteoporosis (Compston, 1990). Researchers
using guinea pigs have also correlated decreased vitamin C supplementation with
decreased bone density (Kipp, 1996).
Nutrition and Aging
With aging there is a relative decrease in the ability to absorb nutrients.
Vitamin deficiencies have been reported in relatively healthy elderly individuals.
These include Vitamins B-6, B-12, D, Calcium and Zinc. Decreased dietary
intake o f fat, protein and calories have also been shown with increased age
(Heuther, 1994). McAlindon (1996b) demonstrated that low blood levels of
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Vitamin D were correlated with decreased joint space and increased osteophyte
growth. However, no studies could be found that investigate the effect o f
decreased intake or absorption o f basic collagen components, such as proline,
lysine and glycine, and their relation to Osteoarthritis.
Functional Tests/Outcome Measures
The Arthritis Impact Measurement Scale 2 (AIMS2) is a 78 item selfreport questionnaire (Appendix B). It is composed of three factors including pain,
psychological status, and physical health status. Scales include mobility, walking
and bending, hand function, arm function, self-care, household, social, family
support, pain, work, tension, mood, satisfaction, perception o f health, and impact
o f arthritis (Meenan, 1992). This tool was designed specifically for individuals
with rheumatic diseases. There are between 2 and 6 responses for each question,
depending on the wording. These are raw scores that are then converted to a scale
o f 0-10 for statistical purposes (Meenan, Gertman, Mason, and Dimaif, 1982).
Test-retest reliability for this measurement tool ranged from .78- 96, and internal
consistency ranged from .74-.96 (Meenan, 1992).
Summarv and Implications for Studv
Arthritis is a condition of excessive breakdown o f articular cartilage.
Bioavailability o f components for collagen synthesis is an important factor in the
formation of healthy cartilage. Appropriate building blocks including amino
acids; glycine, proline and hydroxyproline, and lysine are necessary to maintain
and repair articular cartilage. Gelatin contains hydroxyproline, hydroxylysine and
arginine (Adams, 1991). Vitamin C is an important cofactor in collagen synthesis
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and is involved in the hydroxylation o f Type II collagen which promotes the
stability of collagen (Altman, 1990). Calcium supplementation may help
maintain bone mineral density (Compston, 1990). Nutritional supplementation
has been shown to improve the quality of cartilage by increasing the amount of
essential nutrients required to maintain healthy cartilage and to repair damaged
cartilage.
Moderate levels o f exercise have also been found to decrease pain and
increase function in people with Osteoarthritis. The intermittent compression,
decompression and gliding associated with moderate exercise has been shown to
build and maintain healthy cartilage. It allows for an increased flow o f synovial
fluid into the joint and into the cartilage. Exercise also provides increased
stability to the joint and stimulates the chondrocytes causing increased synthesis
o f articular cartilage in response to the increased stress demands.
By combining a nutritional supplementation, Knox Nutrajoint, with
moderate exercise, the authors o f this study hoped to provide optimal conditions
to allow nutrients to diffuse into the jo in t Theoretically, this combination of
treatments should outweigh the benefits of either nutritional supplementation or
exercise alone.
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CHAPTERS
METHODOLOGY
Design
This experimental study utilized a 2 x 2 factorial design to determine the
efRcacy of moderate exercise and nutritional supplementation in the treatment of
people with Osteoarthritis of the knee. The study was double blinded for
nutritional supplementation only. Subjects were randomly assigned to one o f four
treatment groups for a period o f 8 weeks. One group of subjects was put on a
progressive walking program and consumed a placebo nutritional supplement
(maltodextrin). A second group o f subjects consumed a nutritional supplement,
Knox Nutrajoint®. A third group o f subjects consumed Knox Nutrajoint and was
put on a progressive walking program. The fourth group o f subjects consumed
only a placebo nutritional supplement (maltodextrin). Each subject completed the
Arthritis Impact Measurement Scale 2 (Appendix A) before and after the
treatment program. The pre-test and post-test scores were evaluated to measure
treatment effects. This design was chosen to determine if there is a significant
statistical difference between treatment groups and to identify if there is an
interaction between the independent variables; moderate exercise and the
nutritional supplementation.
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Population and Sample
Voluntary subjects were recruited fix>m southeast and southwest Michigan.
Subjects were obtained from churches, assisted living centers. University faculty
and staff, through newspaper articles, news and radio broadcasts, ads in Michigan
newspapers and community postings (Appendix B). After approval was attained
from the Human Subjects Review Board at Grand Valley University, letters were
sent out to prospective sites o f subject acquisition to ask for permission to give a
group presentation. Potential subjects who were interested in addressing knee
pain secondary to Osteoarthritis were asked to volunteer for this study.
There were 49 participants in this study. Subjects were men (15) and
women (34) between the ages o f 40 and 85, with a mean age of 58.9 years and a
standard deviation o f 11.7 years. The subjects had been diagnosed with
Osteoarthritis between zero and 30 years. The average years with diagnosis of
OA in one or both knees was 9.8 with a standard deviation o f 8.21 years.
Potential subjects were given the inclusion/exclusion questionnaire
(Appendix C) to determine if they were eligible to participate in the study.
Subjects were excluded if they had been diagnosed with Diabetes, Rheumatoid
Arthritis, or Peripheral Vascular Disease, if they were consuming supplements of
chondroitin sulfate, glucosamine sulfate or gelatin supplements, if they could not
walk for 20 minutes at a time or had sensory loss in their lower extremities, had
compromised cognitive status, or other unresolved pathology in the knee that
would prevent them from taking part in a walking program. Subjects were also
excluded if they were currently involved in any type o f lower extremity exercise
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program three or more times per week with each session lasting 15 minutes or
longer in duration.
Instruments/Materials

All of the subjects were evaluated before and after treatment with the
Arthritis Impact Measurement Scale 2 (AIMS2). This instrument was a
subjective self-report questionnaire that addressed many issues such as pain and
ftmctional status. As well as completing the A1MS2, each subject was given log
sheets to record information on a daily basis (Appendix D). The log sheets
measured compliance with nutritional supplement consumption and the walking
program.
The placebo treatment was maltodextrin and the nutritional supplementation was
Knox Nutrajoint® which contains 10 grams o f hydrosylated gelatin, 60
milligrams of Vitamin C (100% o f RDA), and 300 milligrams o f Calcium (30%
RDA). Both the placebo and the Knox Nutrajoint came in powder form that was
mixed into a preferred beverage for consumption.
The Nabisco Corporation for the purpose o f this study donated the Knox
Nutrajoint and the placebo (maltodextrin). Nabisco packaged the Nutrajoint and
the placebo in identical single serving envelopes. Envelopes were coded either
“A” or “B” to conceal the identity o f the contents to both the researchers and the
subjects until the results o f the study were analyzed. The Nabisco Company gave
a gift of $7,500 to Grand Valley State University to help defiay the costs involved
in conducting this study. Funding allowed the researchers to increase the number
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o f subjects that could be managed in this study by hiring part time research
assistants and for advertising for potential subjects.
Procedures
Subject recruitment began on June 1, 1998 and ended January 15, 1999.
Researchers recruited subjects in two major ways. The first method o f subject
recruitment involved going to various senior centers to meet with groups o f
potential subjects for the study. At the initial meeting, a description o f the study
was provided. Participants were asked to volunteer for the study. All potential
subjects were given or asked the inclusion/exclusion questionnaire. From the
results o f this questionnaire the researchers determined who was eligible for the
study. Those volunteers who were not eligible for the study were given an
arthritis information sheet (Appendix E).
The second method o f subject recruitment involved advertising through
flyers, newspapers, television news broadcasts and a radio interview. Volunteers
who called in response to the aforementioned advertisements were read the
subject questionnaire. Qualified subjects were then asked to participate in the
study. An initial meeting was then scheduled at a convenient location.
All initial meetings were conducted by researchers; Daniel SchefiFer and
Anna Power. At this meeting, the subjects were given an informed consent form
(Appendix F) that was read and signed. The researchers reviewed the consent
form with each subject and answered all questions. A medical release form with a
letter explaining the study (Appendix G) as sent to each subject’s physician to
confirm that they had a diagnosis o f OA in one or both knees. A stamped
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envelope, addressed to the researchers, was enclosed for the physician’s office to
mail back the diagnosis. Documentation o f a diagnosis o f Osteoarthritis in one or
both knees was obtained for each participant in the study.
Subjects then completed the AIMS2. Each subject was randomly assigned
to one of the four treatment groups by choosing an envelope that contained
information for that group. An instruction sheet (Appendix H) describing what
was expected o f their group for the next eight weeks was given to subjects. They
were asked not to change their diets or take any new supplements for the next
eight weeks. The first group of subjects were put on a progressive walking
program and consumed 10 grams (1 packet) o f a placebo nutritional supplement
(maltodextrin) by mixing it into eight ounces or more o f their favorite juice
beverage. The second group o f subjects consumed 10 grams o f Knox Nutrajoint
(1 packet) with eight ounces or more o f their favorite juice beverage. The third
group of subjects consumed a mixture 10 grams (1 packet) o f Knox Nutrajoint
with eight ounces or more o f their favorite juice beverage as well as being put on
the progressive walking program. The fourth group o f subjects consumed a
mixture of 10 grams (1 packet) of a placebo nutritional supplement (maltodextrin)
with eight ounces or more of their favorite juice. Each subject also received log
sheets at this time to record their compliance over the coarse o f the study. A
second copy o f the AIMS2 was given to each subject which was to be completed
immediately at the end o f their eight-week participation in the study. The AIMS2
and the completed log sheets were returned in another stamped envelope
addressed to the researchers.
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At the end of the initial meeting the researchers supplied the subjects with
enough Nutrajoint or placebo (maltodextrin) for eight weeks o f consumption. If
at anytime the subjects ran out o f product they contacted the researchers to be re
supplied immediately. This happened two times during the course o f the study.
One time, a subject moved and lost 2 boxes. Another time, a subject complained
that one box o f envelopes mixed differently than the rest.
A research assistant phoned participants during weeks 1,4 and 8. The
assistant was blinded to the identity o f the nutritional supplement She used a
protocol (Appendix I) to ask participants specific questions and remind them to
fill out their log sheets. If a subject had concerns or questions, the researchers
would call them back to answer their questions. At the conclusion o f the study,
the participants were phoned by another research assistant and informed o f the
identity o f the nutritional supplementation they had been consuming during the
study. This allowed subjects to continue with the therapeutic intervention if they
decided to. After the data was compiled and analyzed, subjects received a mailing
letting them know the outcomes o f this study.
The walking program that the exercise groups followed consisted o f three
sessions per week spread out through the week (Table 3.1). Each subject was
instructed to walk at a comfortable pace. During the first week each session was
15 minutes long. Five additional minutes were added each week from the second
through the fourth week for a total o f 30 minutes o f walking per session by the
fourth week. Thirty-minute sessions were maintained for the remaining four
weeks.
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Table 3.1 Eight W eek W alking Program for Groups 1 and 3
# of days a wk*

walking time (minutes)

25
30
30
*the three weekly walking sessions should be spread out through the week
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Chapter 4
Data Analysis
Techniques o f Data Analysis
All data was entered into a computer text file by a research assistant who
was blinded to the type o f nutritional supplementation. The SPSS 6.1 Statistics
Package was used to assess all data. The data underwent ANOVA to determine
main effects and interactions within and between groups. Alpha levels were set at
<.05.
The AIMS2 scale has 15 separate subscales that were assessed. These
included mobility, walking and bending, hand function, arm function, self-care,
household tasks, social activity, family support, arthritis pain, work related
activities, level o f tension, mood, satisfaction, health perception and arthritis
impact.
Data Analvsis
Internal Consistency/Reliability
The internal consistency o f each o f these scales were calculated using
coefficient Alpha. Only nine o f the subscales were found to be reliable. The
results of the internal consistency calculations are reported in table 4.1.
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For the calculation of overall functionality, the mobility, self care and
household task subscales were excluded due to little or no variability. The
internal consistency o f the remaining scales ranged from .63 to .94.
The work related activities subscale was also excluded from the overall
functionality calculation due to missing data. This was caused by the AIMS2
scale requiring respondents to skip a section if they were retired, this happened
with 20 o f the subjects.
T able 4.1: Coefficient Alpha Values for AIMS2 Subscales
Coefficient Alpha
Scale

Pretest

Post-test

Mobility
Walk/Bend
Hand
Arm
Self Care
Household
Social
Family
Pain
Work
Tension
Mood
Satisfaction
Overall

.56
.73
.94
.92
-.11
0
.80
.89
.82
.86
.93
.88
.84
.78

.33
.79
.78
.89
0
0
.62
.90
.68
.63
.85
.92
.81
.82

Analysis o f Covariance
ANCOVA, or Analysis o f Covariance, were conducted for those subscales
demonstrating reliability. Two subscales. Health Perception and Arthritis Impact,
that had single response subscales were also analyzed. As each subscale was

28

analyzed separately. Alpha was set at .05 divided by the number o f subscales (13),
.004.
Analysis of Covariance indicated no significant effect for walking and
bending for the gelatin condition F (3,41) = .59, p=.448 or for the walking
condition F(3,41) = .48, p=.494. The pretest and posttest means for group 1,
exercise only, were 5.733, S.D. ± 2.535 and 4.567, S.D. ± 2.597 (See figure 4.1),
for group 2, placebo, were 3.35, S.D ± 2.729 and 4.15, S.D ± 2.973, for group 3,
gelatin and exercise, were 4.536, S.D. ± 2.545 and 3.607, S.D. ± 2.422, for group
4 were 4.8, S.D ± 1.719, and 4.1, S.D. ± 2.601

(Pretest
I Posttest

exercise only

placebo

exercise and
gelatin

gelatin only

Figure 4.1: M ean Scores for Walking and Bending Subscale.

Analysis of Covariance revealed a significant effect for level o f mood in
both the exercise groups F(3,41) =9.09, p=.004. No significant effect was noted
for the gelatin condition F (3 ,41) = 1.25, p=.270. The pretest and posttest means
for the exercise only group were 3.033, S.D. ±2.125 and 2.300, S.D. ±2.210 (See
Figure 4.2), for the placebo group were 2.45, S.D ± 2.034 and 3.10, S.D ± 1.969,
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for the exercise and gelatin group were 2.143, SJ3. ± 1.447 and 1.786, S.D. ±
1.805, for the gelatin only group were 1.85, S.D ± .937, and 1.700, S.D. ± .919.

g Pretest
Posttest

exercise only

placet»

exercise and gelatin only
gelatin

Figure 4.2: Mean Scores for Mood Subscale
Analysis o f Covariance revealed no significant effect on pain for the
Exercise condition F(3,41) = 1.18, p=.285. There was no significant effect for
the gelatin condition F(3,41) = 1.68, p = .202. The pretest and posttest means for
the exercise group were 5.567, S.D. ± 2.086 and 3.967, S.D. ± 1.968. (See Figure
4.3), for the placebo group were 5.50, S.D ± 2,273 and 4.40, S.D ± 2.633, for the
exercise and gelatin group were 4.643, S.D. ± 2.033 and 3.786, S.D. ±1.862, for
group gelatin only group were 5.20, S.D ± 1.829, and 3.500, S.D. ± 1.528.
Analysis o f Covariance revealed no significant effect on work related
activities for the Exercise condition F(3,20) = 0, p=.997. There was no
significant effect for the gelatin condition F(3,20) = .54, p = .473. The pretest and
posttest means for the exercise group were 4.306, S.D. ± 4.446 and 2.986, S.D. ±
4.155 (See Figure 4.4), for the placebo group were .714, S.D ± .431 and .714, S.D
± .759, for the exercise and gelatin group were 2.109, ST). ± 2.692 and 1,250,
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S.D. ±1.157. The pretest and posttest means for the gelatin only group were
1.406, S.D ± 1.288, and .625, ST). ± .510.

^Pretest

exercise only

placebo

exercise and
gelatin

gelatin only

Figure 4 3 : Mean Scores for A rthritis Pain Subscale

Analysis of Covariance revealed no significant effect on level o f
satisfaction for the Exercise condition F (3,41) = .42, p=.520. There was no
significant effect for the gelatin condition F (3 ,41) = .61, p = .440. The pretest and
posttest means for the exercise group were 3.583, S.D. ± 2.139 and 2.528, S.D. ±
1.467 (See figure 4.5), for the placebo group were 2.979, S.D ± 2.282 and 2.729,
S.D ± 2.392, for the exercise and gelatin group were 2.515, S.D. ± 1.633 and
2.381, S.D. ±1.155, for the gelatin only group were 3.125, S.D ± .977 and .2.625,
S.D .± 1.996.
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4 .5

|P te te st
■P osttest j

exercise only

placebo

exercise and gelatin only
gelatin

Figure 4.4: M ean Scores for W ork Related Subscale

Ba
exercise only

placet»

Ig Pretest
■Posttest I

exercise and gelatin only
gelatin

Figure 4.5: M ean Scores for A rthritis Satisfaction Subscale

The Analysis o f Covariance for overall Arthritis Impact was not
significant for the exercise condition F (3,41)= 4.05, p=.325. The gelatin
condition was also not found to be significant F (3,41) = 10.68, p=.l 14. The
reliability Coefficient was found to be .8193 for this subscale. The pretest and
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posttest means for the exercise group were 5.000, S JD. ± 2.673 and 3.333, S.D. ±
3.086 (See Figure 4.6), for the placebo group were 5.250, S.D ±2.189 and 3.500,
SJ3 ± 3.375, for the exercise and gelatin group were 4.107, SJ). ± 2.322 and
3.393, S.D. ± 1.862, for the placebo group were 3.750, S.D ± 2.13 and 3.000, S.D.
±2.297.

|Pretest
■Posttesti

exercise only

placebo

exercise and
gelatin

gelatin only

Figure 4.6: M ean Scores for A rthritis impact
The Analysis o f Covariance for overall Functional Capacity was not
significant for the exercise condition F (3 ,41)= .11, p=.662. The gelatin condition
was also not found to be significant F (3 ,41) = .50, p=.86. The pretest and posttest
means for the exercise group were 3.777, S.D. ± 1.023 and 3.116, S.D. ± 1.047
(See Figure 4.7), for the placebo group were 3.168, S.D ± 1.511 and 3.034, S.D ±
1.721, for the exercise and gelatin group were 2.880, S.D. ± 1.041 and 2.672, S.D.
± .897, for the gelatin only group were 2.934, S.D ± .702 and 2.658, S.D. ± 1.056.
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gPietest
■Posttesti

exercise only

placet»

exercise and gelatin only
gelatin

Figure 4.7 M ean Scores for Overall functional Capacity Subscale

An analysis o f Variance was conducted using the Pain rating scales that
subjects filled out on their log sheets. The average pain ratings o f week 1, week 4
and week 8 were compared. The average pain rating across all four treatment
conditions decreased significantly F(82.2) = 10.61, p=.000. However, there was
no significant main effects within treatment conditions; gelatin, F(82,2) = .83,
p=.442, or exercise F(82,2)=.62, p=.542 (See Table 4.2).
Table 4.2 Mean Pain Ratings for Each Group.
Week 1 mean

Week 4 mean

Week 8 mean

Placebo

4.00

3.60

3.20

Gelatin

4.50

3.917

3.167

Exercise

4.273

3.636

3.455

Exercise and Gelatin

3.333

3.250

2.500

Entire Sample

4.022

3.600

3.067

Standard Deviation

2.190

2.093

1.924
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Hypothesis and Research Question Results
The first hypothesis was that nutritional supplementation o f Knox
Nutrajoint® in combination with a moderate exercise program would be superior
to the effects o f either exercise alone or Knox Nutrajoint alone when compared to
a placebo supplement in the reduction o f pain and subjective increase in function
in subjects with OA o f the knee(s). This was not supported by the results o f this
study.
The second hypothesis was that the treatment groups receiving nutritional
supplementation or exercise would report greater relief o f symptoms than the
group receiving only a placebo. This was not supported by the results o f this
study.

35

Chapter 5
Discussion o f Findings
The purpose o f this study was to compare the effects of a placebo
supplement to 1) exercise alone, 2) a nutritional supplementation o f Knox
Nutrajoint® (which contains gelatin hydrosylate. Vitamin C, and Calcium), and
3) a nutritional supplementation o f Knox Nutrajoint in combination with exercise
in the reduction o f pain and subjective increase o f function in patients with OA of
the knee.
It is well documented in the literature that exercise can produce
significant improvement on both subjective and objective functional testing in
people with OA. The mechanism o f cartilage regeneration has also been
supported by clinically controlled studies. According to Hallet (1994), articular
cartilage and subchondral bone will adapt to increased mechanical stresses by an
increase in thickness. However, if the load is excessive, the cartilage will
deteriorate instead o f regenerate. Therefore, it is important not to exceed the
threshold at which cartilage will begin to deteriorate. Theoretically, it is
necessary to have the appropriate amount o f chondrocytes in the cartilage to assist
in regenerating the cartilage matrix when prescribing exercise treatment.
According to previous research on exercise, the authors expected to find a
significant effect on the reduction o f pain and increase in function with those
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individuals in the exercise conditions o f this study. All o f the other exercise
studies demonstrating an increase in functional variables had physical therapists
or assistants supervise the exercise program (Kovar, 1992; Fisher, 1993; Fisher,
1989). Unlike other studies that looked at the effects of exercise on OA, this
study had no formal supervision o f the subjects’ exercise program to determine if
participants reaching a therapeutic level. Compliance was based on self-report
only. The lack o f significant findings in functional variables could be attributed
to a lack of supervision.
Another possibility was that eight weeks was not a long enough time
period to see significant effects o f a non supervised home walking program or
nutritional supplementation. Previous research investigating exercise on OA of
the knee has been 3 to 18 months in duration (Minor, 1989, Fisher, 1993, Ettinger,
1997). Oberschelp (1985) investigated gelatin supplementation for 3 months.
Another factor that may have contributed to the lack of significant
improvement of the exercising groups over non exercise groups was the variation
in stage of arthritic degeneration in each subjects’ knees. Because there was no
control for the stage or level o f arthritis, there was no way to determine if a
subject had enough chondrocytes remaining in their knee for effective
regeneration of the cartilage.
Neither the gelatin condition nor the exercise condition demonstrated any
statistical significance in the comparative reduction of pain or increase in
function. Previous studies that were done on gelatin have demonstrated some
significant results in mobility and pain status (Adams, 1991, Oberschelp, 1985).
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However, most o f these studies lacked appropriate controls and used poor
measurement tools. The only double blind placebo study that reported significant
effects o f gelatin on the reduction o f pain was by Adams (1991). This study relied
on subjective ordinal data and utilized only a chi-square analysis for their
statistics.
The results o f this study did not support the findings reported in the above
gelatin studies. Previous gelatin studies utilized chi-squared tests whereas this
study used the more statistically powerful ANOVA and ANCOVA. The results o f
this study, coupled with the use o f parametric statistics, may imply that a type 1
error could have occurred in the previous studies.
All subjects, regardless o f the group they were in, demonstrated an equal
decrease in perceived pain scores between weeks one and eight o f the study.
These results could be attributed to the placebo effect since the subjects were
blinded to the type o f nutritional supplement that they received.
Rene (1982) discovered that if patients with OA of the knee received a
phone call firom a trained "layperson" once a month, there was a significant
decrease in pain in the knee, regardless of their stable medical regime. This
phenomenon could explain why all of the treatment groups had a decrease in pain,
as they were called in week one, week four and week eight during their
participation in this study.
The exercise group did exhibit a statistically significant increase in mood
compared to the non exercise groups. The increase in wellness and overall well
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being scores had been found to increase in exercise groups in other studies as well
(Minor, 1989; Kovar, 1992).

Application o f practice
There is an abundance o f research using ANOVA and measures with strong
validity and reliability that demonstrate the efficacy of a well controlled and
supervised exercise program on the treatment o f OA (Minor, 1989, Ettinger, 1997,
Fischer, 1993). There is also some evidence to recommend gelatin
supplementation (Adams, 1991, Oberschelp, 1985). However, the results of this
study could not support the recommended use o f gelatin supplementation or an
unsupervised walking program for the treatment o f osteoarthritis o f the knee.
Limitations
This study did not control for the stage or the severity o f arthritic
degeneration that each subject had. Nor was the diagnosis o f Osteoarthritis
classified as to the specific type patellofemoral, tricompartmental or
unicompartmental. The stage of arthritis has been shown in other studies to be an
important indicator o f success of nutritional intervention. Incident arthritis, or
arthritis caused by trauma was only controlled for by excluding individuals under
40 years o f age as they seem to have a higher incidence of this form o f arthritis.
One o f the most significant limitations o f this study was the lack of control
for the subject’s diet. Other than documenting estimated calcium and caffeine
intake in the logbook, there were no regulations on each subject’s diet. This could
have effected the results if any of the subjects radically change their diet during
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the course o f the study. Subjects that began to consume high amounts o f Vitamin
C or products containing gelatin, would have changed the controlled amount o f
supplementation that they were receiving each day. The authors o f this study
attempted to control for this by asking subjects to maintain their current diet and
to refrain from adding any additional supplements for eight weeks. There were
also no baseline diet requirements or inclusion/exclusion criteria before the
intervention. This may have been relevant since the researchers were basing the
theoretical need for supplementation on the lack of proper amounts within the
person’s diet
This study did not control for the occupations and day to day physical
demands o f each of the subjects. Determining the correct amount o f physical
activity to promote joint healing is important in managing OA. Because the
subjects were not being asked to control the amount of physical activity outside
the treatment protocol, some may have exceeded the amount of physical activity
that would foster improvement and produced some degree o f pain and
inflammation. Others may not have had an adequate amount of activity to
stimulate sufficient improvement in the cartilage matrix to show any significant
change in pain or function. This could also have affected the outcome o f this
study.
Although the amount o f pain medication was monitored, it could have
been a confounding variable with respect to pain reduction. Other orthopedic
dysfunction at the ankle or hip was not controlled for as the only requirement was
walking time of 15 minutes or more and no previous surgery within 6 months.
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Another limitation to this study was the use o f only subjective self-report
measurement outcomes. Also, there was no formal cognitive measure, which may
have been important for a purely subjective outcome measure which required
completion o f a detailed questionnaire. The results were subject to self-report
honestly and compliance.
The length o f the study was only eight weeks, which is generally accepted
to be the minimal amount o f time to report subjective change in pain and function
with gelatin supplementation. It may have proved more significant had the length
of the study been increased to 6 months or more to allow for a plateau effect
Another factor that might have affected some subjects’ responses to
Nutrajoint was that they were not excluded if they had tried chondroitin sulfate,
glucosamine sulfate or gelatin in the recent past. It is estimated that 20-50% of
the population does not respond to chondroitin sulfate or glucosamine sulfate
(Schardt, 1998). It is unknown if this applies to gelatin supplementation with the
small sample sizes in this study, 11 to 12 subjects per group, a 20-50% non
response level to gelatin supplementation could dramatically effect the results.
Familial disposition for arthritis was not investigated. There may be a
genetic component to arthritis that responds differently to nutritional intervention.
And last of all, by limiting the focus of this research to the knee, the results o f this
intervention may not be applicable to other arthritic joints, especially non weight
bearing joints.
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Suggestions for Further Research/Modifications
Modifications to this study should include the use of a shorter subjective
measurement test. The AIMS2 took up to an hour to complete in several cases.
Advising patients to consume the supplementation after eating a meal may have
reduced stomach discomfort experienced by a few o f the volunteers. Also, the
diagnosis o f renal dysfunction should have been added to the exclusion criteria
due to the inability to tolerate higher levels o f protein that gelatin contains.
More research needs to be done in the investigation o f gelatin and exercise
on arthritis. Suggestions for future research include comparing the effect o f
glucosamine sulfate to that o f gelatin on arthritis. The stage o f the arthritis should
also be controlled for in order to determine the most effective or least effective
time in the progression o f OA for nutritional intervention. The exercise
component should be treated as one of the controlled variables but not as an
imposed control as it limited the amount o f subjects that qualified for this study
by 50%. Larger sample sizes should also be investigated. Also, the response of
other arthritic joints to exercise and nutritional supplementation should be
examined. The duration o f this type o f study should be increased and the type of
exercise could be tailored towards the current activity level o f each subject to
insure that therapeutic levels are attained. A follow up study should be considered
as well to examine any long-term benefits o f nutritional supplementation.
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Conclusion/Summary
Despite significant findings in the literature that support the benefits o f
gelatin supplementation and exercise in the treatment o f OA, the results o f this
study did not support the beneficial effects o f either gelatin supplementation or of
an unsupervised walking program in the treatment o f OA o f the knee in people
over the age o f 40 years. The data indicted that there was a significant
improvement in the self reported mood level in the exercise groups when
compared to non exercise groups. There was a significant reduction in the
perceived pain scores across all four treatment groups. Further study involving
more subjects, better supervision o f exercise, a longer time interval and a less time
consuming subject self assessment tool is recommended.
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Appendix A
TheAIMS2
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Adm#_
Card

1-4/
5-61

It*

#1

ARTHRITIS IMPACT MEASUREMENT SCALES 2
(AIMS2)

Instructions: Please answer the following questions about your health. Most questions ask about your health during the
past month. There are no right or wrong answers to the questions and most can be answered with a simple
check (O - Please answer every question.

Please begin by providing the following information about yourself.

NAME:
ADDRESS:
Street

Number

City

Apt;*

State

Zip Code

DATE:

PHONE:
Area Code

Number

Month

Day

Year

AIMS2 Copyright 1990 Boston University
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Please check (O the most ^propriété answer for each question.
These questions refer to MOBILITY LEVEL.
DURING THE PAST MONTH ...

All
Days
(I)

Most
Days
(2)

Some
Days
(3)

Few
Days
(4)

No
Days
(5)

1. How often were you physical able to drive a car
or use public transportation?

8/

2. How often were you out o f the house for at least
part o f the day?

9/

3. How often were you able to do errands in the
neighborhood?
4. How often did someone have to assist you to get
around outside your home.

_____

_____

_____

_____

_____

Most
Days
(2)

Some
Days
(3)

Few
Days
(4)

No
Days
(5)

11/

5. How often were you in a bed or chair for most or
all o f the day?

These questions refer to W ALKING AND BENDING.

DURING THE PAST MONTH ...

All
Days
0)

6. Did you have trouble doing vigorous activities
such as running, lifting heavy objects, or
participating in strenuous sports?

13/

7. Did you have trouble either walking several
blocks or climbing a few flights o f stairs?

14/

8. Did you have trouble bending, lifting or
stooping?

15/

9. Did you have trouble either walking one block or
climbing one flight o f stairs?

16/

10. Were you unable to walk unless assisted by
another person or by a cane, crutches, or walker?

_____

17/
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Please check (O the most appropriate answer for each question.

These questions refer to BLAND AND

FIN G ER FUNCTION.

DURING THE PAST MONTH...

All
Days
(I)

Most
Days
(2)

Some
Days
(3)

Few
Days
(4)

No
Days
(5)

11. Could you easily write with a pen or pencil?

18/

12. Could you easily button a shirt or blouse?

19/

13. Could you easily turn a key in a lock?

20/

14. Could you easily tie a knot or a bow?

21/

15. Could you easily open a new jar o f food?

22/

These questions refer to ARM

FUNCTION.

DURING THE PAST MONTH ...

All
Days
(I)

Most
Days
(2)

Some
Days
(3)

Few
Days
(4)

No
Days
(5)

16. Could you easily wipe your mouth with a
napkin?

23/

17. Could you easily put on a pullover sweater?

24/

18. Could you easily comb or brush your hair?

25/

19. Could you easily scratch your low back with
your hand?

26/

20. Could you easily reach shelves that were above
your head?

27/
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Please check ( / ) the most appropriate answer for each question.

These questions refer to SELF-CARE

TASKS.

DURING THE PAST M ONTH...

Always
(1)

21. Did you need help to take a bath or a shower?

____

Very
Often
(2)

Sometimes
(3)

Almost
Never
(4)

Never
(5)
28/

22. Did you need help to get dressed?

29/

23. Did you need help to use the toilet?

30/

24. Did you need help to get in or out o f bed?

These questions refer to

_____

_____

_____

_____

_____

Always
(I)

Very
Often
(2)

Sometimes
(3)

Almost
Never
(4)

Never
(5)

31/

HOUSEHOLD TASKS.

DURING THE PAST M ON TH...

25. If you had the necessary transportation, could
you go shopping for groceries without help?

32/

26. If you had kitchen facilities, could you prepare
your own meals with out help?

33/

27. If you had household tools and appliances, could
you do your own house work without help?

34/

28. If you had laundry facilities, could you do your
own laundry without help?

35/
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Please check

the most appropriate answer for each question.

These questions refer to

SOCIAL ACTIVITY

DURING THE PAST MONTH...

All
Days
(I)

Most
Days
(2)

Some
Days
(3)

Few
Days
(4)

No
Days
(5)

29. How often did you get together with friends or
relatives?

36/

30. How often did you have fnends or relatives over
to your home?

37/

31. How often did you visit friends or relatives at
their homes?

38/

32. How often were you on the telephone with close
friends or relatives?

39/

33. How often did you go to a meeting of a church,
club, team, or other group?

40/

These questions refer to

SUPPORT FROM FAM ILY AND FRIENDS.

DURING THE PAST MONTH...

Always
(1)

Very
Often
(2)

Sometimes
(3)

Almost
Never
(4)

Never
(5)

34. Did you feel that your family or friends would
be around if you needed assistance?

41/

35. Did you feel that your family or fnends were
sensitive to your personal needs?

42/

36. Did you feel that your ftmily or fnends were
interested in helping you solve problems?

43/

37. Did you feel that your family or fnends
understood the affects of your arthritis?

44/
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Please check (■<^) the most appropriate answer for each question.

These questions refer to

ARTHRITIS PAIN.

DURING THE PAST M ON TH...

Severe

Moderate

(I)

(2)

Mild
(3)

Very Mild
(4)

None
(5)

38. How would you describe the arthritis pain you
usually had?

45/
All
Days
(I)

Most
Days
(2)

Some
Days
(3)

Few
Days
(4)

No
Days
(5)

39. How often did you have severe pain from
arthritis?

46/

40. How often did you have pain in two or more
joints at the same time?

47/

41. How often did your morning stiffiiess last more
than one hour from the time you woke up?

48/

42. How often did yoim pain make it difticult for
you to sleep?

49/

These questions refer to

W ork.

DURING THE PAST MONTH ...

Paid
Work

House
Work

( 1)

(2)

School
Work
(3)

Unemployed
(4)

Disabled
(5)

Retired
(6)
50/

43. What has been your main form o f work?
If you answered unemployed, disabled, or retired, please skip the next four questions and go to the next page.

DURING THE PAST MONTH ...

All
Days
(1)

Most
Days
(2)

Some
Days
(3)

Few
Days
(4)

No
Days
(5)

44. How often were you able to do any paid work,
house work, or school work?

51/

45. On the days that you did work, how often did
you have to work a shorter day?

52/

46. On the days that you did work, how often were
you unable to do your work as carefully and
accurately as you would like?

53/

47. On the days that you did work, how often did you
have to change the way your paid work, house
work, or school work is usually done?

54/
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Please check

Ûie most ^propriate answer for each question.

These questions refer to LEVEL

O F TENSION.

DURING THE PAST MONTH...

Always
(1)

Very
Often
(2)

Sometimes
(3)

Almost
Never
(4)

Never
(5)

48. How often have you felt tense or high strung?

55/

49. How often have you been bothered by
nervousness or your nerves?

56/

50. How often were you able to relax without
difficulty?

57/

51.- How often have you felt relaxed and ftee of
tension?

58/

52. How often have you felt calm and peaceful?

59/

These questions refer to MOOD.

DURING THE PAST MONTH ...

Always

Very
Often

(I)

(2)

Sometimes
(3)

Almost
Never
(4)

Never
(5)

53. How often have you enjoyed the things you do?

60/

54. How often have you been in low or very low
spirits?

61/

55. How often did you feel that nothing turned out
the way you wanted it to?

62/

56. How often did you feel that others would be
better o ff if you were dead?

63/

57. How often did you feel so down in the dumps
that nothing would cheer you up?

64/
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Please check (^O &e most appropriate answer for each question.

These questions refer to satisfaction with each health area.

DURING THE PAST M ONTH...

Very
satisfied
(1)

Somewhat
Satisfied
(2)

Neither
Satisfied
Nor Dissatisfied
(3)

Somewhat
Dissatisfied
(4)

Very
Dis
satisfied
(5)

58. How satisAed have you been with each o f
these areas o f your health?
MOBILITY LEVEL
(example; do errands)

65/

WALKING AND BENDING
(example: climb stairs)

66/

HAND AND FINGER FUNCTION
(example: tie a bow)

67/

ARM FUNCTION
(example: comb hair)_______________________________________

._

68/

SELF-CARE
(example: take bath)

69/

HOUSEHOLD TASKS
(example: housework)

70/

SOCIAL ACTIVITY
(example: visit fnends)

71/

SUPPORT FROM FAMILY
(example: help with problems)

72/

ARTHRITIS PAIN
(example: joint pain)

73/

WORK
(example: reduce hours)

74/

LEVEL OF TENSION
(example: felt tense)

75/

MOOD
(example: down in dumps)

76/
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ID 1-4/
Adnrf 5-6/
Card #2 7/
AIMS

Please check ( ^ ) the most appropriate answer for each question.
These questions refer to arthritis impact on each area o f health.

DURING THE PAST MONTH ...

N o ta
Problem
For Me
(0)

Due
Entirely
To Other
Causes
(I)

Due
Largely
To Other
Causes
(2)

Due Partly
to Arthritis
and Partly
to Other
Causes
(3)

Due
Largely
To My
Arthritis
(4)

Due
Entirely
To My
Arthritis
(5)

59. How much o f your problem in
each area o f health was due to
your arthritis?
MOBILITY LEVEL
(example: do errands)
WALKING AND BENDING
(example: climb stairs)

8/

9/

HAND AND FINGER FUNCTION
(example: tie a bow)

10/

ARM FUNCTION
(example: comb hair)

11/

SELF-CARE
(example: take bath)

12/

HOUSEHOLD TASKS
(example: housework)

13/

SOCIAL ACTIVITY
(example; visit friends)

14/

SUPPORT FROM FAMILY
(example: help with problems)

15/

ARTHRITIS PAIN
(example: joint pain)

16/

WORK
(example: reduce hours)

17/

LEVEL OF TENSION
(example: felt tense)

18/

MOOD
(example: down in dumps)

19/
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You bave now answered questions about different AREAS OF YOUR HEALTH. These areas are listed below. Please
check ( / ) up to THREE AREAS in which you would MOST LIKE TO SEE IMPROVEMENT. Please read all 12 areas o f
health choices before making your decision:
Check = 1
Blank = 0

60. AREAS OF HEALTH

THREE AREAS FOR IMPROVEMENT

MOBILITY LEVEL
(example: do errands)

20/

WALKING AND BENDING
(example: climb stairs)

21/

HAND AND FINGER FUNCTION
(example: tie a bow)

22/

ARM FUNCTION
(example: comb hair)

23/

SELF-CARE
(example: take bath)

24/

HOUSEHOLD TASKS
(example: housework)

25/

SOCIAL ACTIVITY
(example: visit fnends)

26/

SUPPORT FROM FAMILY
(example: help with problems)

27/

ARTHRITIS PAIN
(example: joint pain)

28/

WORK
(example: reduce hours)

29/

LEVEL OF TENSION
(example: felt tense)

30/

MOOD
(example: down in dumps)

31/

Please make sure that you have checked no more than THREE AREAS for improvement
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Please check (^ ) the most appropriate answer for each question.

These questions refer to your CURRENT and FUTURE HEALTH.
Excellent
( 1)

Good

Fair
(3)

(2)

Poor
(4)

61. In general would you say that your HEALTH NOW is
excellent, good, fair, or poor?

Very
Satisfied
(1)

32/

Somewhat
Satisfied
(2)

Neither
Satisfied
Nor Dis
satisfied
(3)

Somewhat
Dissatisfied
(4)

Very Dis
satisfied
(5)

62. How satisfied are you with your
HEALTH NOW?

33/

Nota
Problem
For Me
(0)

Due
Entirely
To Other
Causes
(1)

Due
Largely
To Other
Causes.
(2)

Due Partly
to Arthritis
and Partly
to Other
Causes
(3)

Due
Largely
To My
Arthritis
(4)

Due
Entirely
To My
Arthritis
(5)

63. How much o f your problem
with your HEALTH NOW is
due to your arthritis?

34/

Excellent

(0

Good
(2)

Fair
(3)

Poor
(4)

64. In general do you expect that your HEALTH 10
YEARS FROM NOW will be excellent, good, fair, or
poor?

35/

No Problem
At All
(1)
65. How big a problem do you expect your arthritis to be
10 YEARS FROM NOW?

Minor
Problem
(2)

Moderate
Problem
(3)

Major
Problem
(4)

36/
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Please check ( y ) the most appropriate answer for each question

This question refers to OVERALL ARTHRITIS IMPACT.
Very Well
(1)

Well
(2)

Fair
(3)

Poor
(4)

Very Poorly
(5)

66. CONSIDERING ALL THE WAYS THAT
YOUR ARTHRITIS AFFECTS YOU. how
well are you doing compared to other people
your tige?

37/

What is the main kind o f arthritis that you have?

Check = I
Blank = 0

Rheumatoid Arthritis

38/

Osteoarthritis/Degenerative Arthritis

39/

Systemic Lupus Erythematosis

40/

Fibromyalgia

41/

Scleroderma

42/

Psoriatic Arthritis

43/

Reiter’s Syndrome

44/

Gout

45/

Low Back Pain

46/

Tendonitis/Bursitis

47/

Osteoporosis

48/

Other

49/

68. How many years have you had arthritis?

DURING THE PAST M ONTH...

69. How often have you had to take MEDICATION
for your arthritis?

50-51/

All
Days
(I)

Most
Days
(2)

Some
Days
(3)

Few
Days
(4)

No
Days
(5)

52/
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Please check (^ ) yes or no for each question.

70. Is your health currently affected by any of the following medical problems?
Yes

No

(I)

(2)

High blood pressure_________________________________

53/

Heart disease______________________________________

54/

Mental illness______________________________________

55/

Diabetes__________________________________________

56/

Cancer___________________________________________

57/

Alcohol or drug u s e _________________________________

58/

Lung disease_______________________________________

59/

Kidney disease_____________________________________

60/

Liver disease_______________________________________

61/

Ulcer or other stomach disease________________________

62/

Anemia or other blood disease_________________________________

63/

Yes

No

( 1)

(2)

71. Do you take medicine every day for any problem other than
your arthritis?

72. Did you see a doctor m ore than three times last year for any
problem other than arthritis?

64/

Yes

No

(I)

(2)
65/
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Please provide the fcliowing information about yourself:

73. What is your age at this time?

66-67/

74. What is your sex?
Male (1)
Female (2)_________________________________________________ _____

68/

75. What is your racial background?
White (I)
Black (2)________________________________________________________
Hispanic (3)________________________________________________ _____
Asian or Pacific Islander (4)
_____
American Indian or Alaskan Native (5)
_____
Other (6)
_____

69/

76. What is your Current marital status?
Married (1)
Separated (2)_______________________________________________ _____
Divorced (3)________________________________________________ _____
Widowed (4)_______________________________________________ _____
Never married (5)
_____

70/

77. What is the highest level of education you received?
Less than seven years o f school (1)
Grades seven through nine (2)
Grades ten through eleven (3)
High school graduate (4)
One to four years o f college (5)
College graduate (6)
Professional or graduate school (7)_____________________________

71/
_____
_____
_____
_____
_____
_____

78. What is your approximate family income including wages, disability payment,
retirement income, and welfare?
Less than $10,000 (I)
$ 10,000 - $ 19,999 (2)
$20,000 - $29,999 (3)
$30,000 - $39,999 (4)
$40,000 - $49,999 (5)
$50,000 - $59,999 (6)
$60,000 - $69,999 (7)
More than $70,000 (8)_______________________________________

72/
_____
_____
_____
_____
_____
_____
_____

Thank you fo r completing this questionnaire.
Reprinted with Permission. Meenan, Robert F. The Arthritis Impact Measurement Scales. yowna/q/’/Z/icumaro/gy. 1982, Revised
1991. 9:785-788.
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Appendix B
A tte n tio n A rth ritis S u f f e r e r s
I f a p h y s i c i a n h a s d i a g n o s e d y o u w i t h O s t e o a r t h r i t i s in o n e o r
b o t h o f y o u r k n e e s y o u m a y b e e l i g i b l e t o p a r t i c i p a t e in a n e x c i t i n g
n e w s t u d y t h a t is b e i n g c o n d u c t e d t h r o u g h G r a n d V a ll e y S t a t e
U n iv e rs ity .
T h e p u r p o s e o f t h i s s t u d y is t o e x p l o r e a l t e r n a t i v e t r e a t m e n t s
s u c h a s n u tritio n a l s u p p le m e n ta tio n a n d e x e r c is e o n d e c re a s in g p a in
f r o m a r t h r i t i s o f th e k n e e . W e a r e l o o k i n g f o r m e n a n d w o m e n w h o
a r e o v e r 4 0 y e a r s o f a g e . I f y o u w o u ld lik e m o r e in fo rm a tio n a b o u t
th is s tu d y

please call Dan Schaffer and Anna Power at 1-800-7976046.
Osteoarthritis is a disease that destroys the cartilage in the weight bearing
joints o f the body such as knees, hips, ankles and back. With Osteoarthritis, the
body is not able to rebuild cartilage at the same rate that it is being destroyed By
providing the correct nutrition the body can improve i t ’s ability to rebuild
cartilage and decrease pain.
Unfortunately you will NOT be eligible if
• You have a diagnosis o f Diabetes or Peripheral Vascular Disease
• You are currently consuming nutritional supplementation such as; chondroitin sulfate
glucosamine sulfate or gelatin
• If you cannot walk for 20 minutes without stopping
• If you are currently involved in any lower extremity exercise program that you
participate in 3 or more times a week for 1S minutes or more at a time. (Walking,
Biking, Running)
• Loss o f feeling in your legs
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A ppendix C
Subject Q uestionnaire
Circle the Appropriate Response

1. Have you been diagnosed by a physician as having Osteoarthritis
or Degenerative Joint Disease o f one or both knees?

YES

NO

YES

NO

3. Do you ciurently have any numbness or loss o f feeling
in either of your legs?

YES

NO

4. Do you currently have any uiuresolved problems with your
knees other than Osteoarthritis or Degenerative Joint Disease?
If yes, please explain:_____________________________________

YES

NO

5. Are you currently taking any nutritional supplements such as
vitamins. Glucosamine sulfate, chondroitin sulfate, Nutrajoint or minerals?
If yes, what are you tak in g ?________________________________

YES

NO

6. Are you able to walk for 15 minutes continuously without difficulty?

YES

NO

7. Do you perform any type o f exercise including walking on a regular
basis. If yes, please describe what exercise you do, how much
time it involves per week and the number o f times per week that it
is performed.___________________________________

YES

NO

2. Have you ever been diagnosed with Diabetes or Peripheral
Vascular Disease?

Please Print:
Name (first and last)______________________
Mailing Address

______________________

Social Security Num ber

Home Phone ( )_
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Appendix D
Daily Log for Exercise and N utritional Supplementation Groups
Day
Sat.
Date

Sun

Mon.

Tues.

Wed

Consum
ed
Powder
Walked
(record
time)
Amount
of
Pain/anti
inflamm
atory
Medicati
on
#of
drinks
containi
ng
caffeine
++
Pain
rating
(0-10)
0 = no
pain
10=
worst
pain
possible
Calcium
rich
foods
consume
d**
**Calcium rich foods consumed include:

I c. Milk,
Ic. yogurt,
I slice of cheese
1 bowl ice cream.

-H-Caffeine Containing foods include:

I c. Tea
I c. Coffee
I can o f coke/Pepsi/mcimtain dew.
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Thurs.

Friday

Appendix D, cont
Daily Log for N utritional Supplementation only groups
Day
Sat
Date

Sun

Mon.

Tues.

Wed

Thurs.

Friday

Consum
ed
Powder
Amount
of
Pain/anti
inflamm
atory
Medicati
on
#of
drinks
containi
ng
caffeine
++
Pain
rating
(0-10)
0 = no
pain
10=
worst
pain
possible
Calcium
rich
foods
consume
d**

♦♦Calcium rich foods consumed include:
1 c. Milk,
Ic. yogurt,
1 slice o f cheese
1 bowl ice cream.
-H-Caffeine Containing foods include:

1 c. Tea
1 c. Coffee
1 can o f coke/Pepsi/mountain dew.
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Appendix E

A rth ritis In fo rm a tio n
T h a n k y o u fo r y o u r in te re s t in o u r s tu d y . A lth o u g h y o u c a n n o t
p a r tic ip a te , w e w o u ld lik e to s h a r e s o m e in fo r m a tio n th a t m a y b e
h e lp fu l fo r you.
T h e s e a r e s o m e th in g s th a t y o u m a y w a n t to try :

1. Glucosamine Sulfate
2. chondroitin Sulfate
T h e s e s u p p le m e n ts c a n b e f o u n d in m a n y h e a lth fo o d s to re s . T h e y
a re a n im p o rta n t c o m p o n e n t o f th e c a r tila g e in y o u r jo in t. M a n y
p e o p l e h a v e n o t i c e d a d e c r e a s e i n p a i n a f t e r u s i n g th e s e f o r a t l e a s t 2 4 w eeks.

3. Knox Gelatin or Knox Nutraioint®
T h is p r o d u c t c a n b e f o u n d in th e g e la tin a is le o f m a n y g r o c e r y s to re s .
I t c o n ta in s th e a m in o a c id s t h a t a r e u s e d to b u ild T y p e 2 c a r tila g e ,
w h i c h is im p o r t a n t f o r y o u r j o i n t . M a n y p e o p l e h a v e e x p e r i e n c e d a
d e c r e a s e in p a in a f te r ta k in g t h i s d a ily f o r 2 - 4 w e e k s . T h e
r e c o m m e n d e d d o s a g e i s o n t h e c o n t a i n e r ; o n e s c o o p d a i ly .

4. Vitamin C supplements
S o m e p e o p l e r e c o m m e n d t a k i n g V i t a m i n C b e c a u s e it is u s e d w h e n
t h e b o d y is t r y i n g t o m a k e t y p e 2 c a r t i l a g e . I f y o u r d i e t i s l o w i n
V i t a m i n C ( i f y o u d o n ’t e a t m a n y f r u i t s o r d r i n k j u i c e o f t e n ) , i t m a y
a f f e c t t h e s tr e n g t h o f t h e c a r t i l a g e i n y o u r j o i n t .

5. Calcium supplements
C a l c i u m is im p o r t a n t f o r s t r o n g b o n e s . I f y o u r b o n e s a r e n ’t s t r o n g , it
c o u ld a ffe c t h o w s tro n g y o u r jo in ts a re . I f y o u d o n o t c o n s u m e m a n y
d a iry p ro d u c ts , o r i f y o u d r in k a lo t o f c a f f e in a te d p ro d u c ts , y o u m a y
b e n e f i t f r o m c a l c iu m s u p p l e m e n t s .

6. Antioxidants
T h e s e s u p p l e m e n t s m a y h e l p p r o t e c t t h e c a r t i l a g e in y o u r j o i n t f r o m
b e i n g d e s t r o y e d b y f r e e r a d i c a l s . A n t i o x i d a n t s in c lu d e V i t a m i n A ,
V i t a m i n C , V ita m in E , a n d S e l e n i u m .

7. Exercise
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L a te ly , re s e a rc h e rs h a v e r e a liz e d t h a t a c e rta in a m o u n t o f e x e r c is e 3 5 x a w e e k m a y b e h e l p f u l i n m a i n t a i n i n g h e a l th y c a r t i l a g e f o r y o u r
jo in ts . M a n y p e o p le w ith A r th r itis h a v e fo u n d th a t e x e r c is e in
m o d e r a t e a m o u n ts s u c h a s w a l k i n g o r s w i m m i n g h a s h e l p e d r e l i e v e
s o m e o f th e ir p a i n . S p e c i f i c e x e r c i s e s f o r t h e j o i n t h a v e a l s o r e l i e v e d
p a i n i n s o m e i n d i v i d u a l s . I t i s i m p o r t a n t t h a t y o u d i s c u s s n e w e x e r c is e
p r o g r a m s w ith y o u r d o c t o r .

8 . W e ig h t L o ss
I f y o u h a v e a r t h r i t i s i n y o u r l e g s a n d y o u a r e o v e r w e ig h t , y o u r j o i n t s
a r e w o r k in g e x t r a h a r d . B y l o s i n g w e i g h t , y o u a r e d e c r e a s i n g t h e
a m o u n t o f f o r c e t h a t is g o i n g t h r o u g h y o u r c a r tila g e . I t m a y b e
h e l p f u l t o s p e a k t o y o u r d o c t o r i f y o u w i s h to s ta r t a w e i g h t l o s s
p ro g ra m .

These are some things that you may want to try. If your doctor has
prescribed somethingfo r your arthritis, these things may be tried, but
DON’T stop doing what you are already doing without speaking to
your doctor. I f you are thinking o f trying nutritional supplements,
talk to your doctor, a certified nutritionist, or your pharmacist about
what dosage would be most appropriate fo r you.
It is usually recommended that you try one new thing at a time, so
that you can decide what is helpfulfo r you. This is only a partial list,
new research is being conducted all the time to find the best way to
treat Arthritis.
Most o f the information found here can be found in the book The
Arthritis Cure by Jason Theodosakis and Brenda Adderly (1997)
published by St. Martins Paperbacks, NY, NY. I f you want more
detailed information this may be a good place to start.
Another great resource is The Arthritis Foundation. In Grand Rapids the number
is (616) 774-873
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Appendix F

Consent Form
You are invited to participate in a research study entitled The Effects of
Nutritional SuDolementation and Exercise on Subjective Pain and Function
in O steoarthritis of the Knee. This purpose o f this study is to investigate the
effects o f Knox Nutrajoint®, Maltodextrin and walking on Osteoarthritis. This
study is being conducted through the Grand Valley State University Physical
Therapy program. Dan Scheffer and Anna Power are the principal investigators
for this research and it is being funded by the Nabisco Corporation. Nabisco will
provide the Knox Nutrajoint and Maltodextrin as well as all mailing materials free
o f charge.
In order to be included in this studv:
you must be above 40 years of age
you must be able to walk for 15 minutes at a time without supervision.
you must have doctor diagnosis of Osteoarthritis or Degenerative Joint Disease in one or both
knees
You will be excluded from this studv:
If you have had joint replacement surgery in both o f your Osteoarthritis knees
If you have had &actures or tendon tears within the last 90 days in your Osteoarthritis knee(s).
If you have been diagnosed with Diabetes of Peripheral Vascular Disease.
If you are unable to walk for 15 minutes at a time without supervision
If you have been exercising your legs at least 3x a week, 15 minutes at a time (such as water
aerobics, aerobics, walking, biking).

You will be randomly assigned to one of the following four groups ( a process
similar to flipping a coin).
A. Walking 3x a week and drinking maltodextrin daily
B. Walking 3x a week and drinking Knox Nutrajoint daily
C. Drinking maltodextrin daily
D. Drinking Knox Nutrajoint daily
You will not be told if you are receiving Maltodextrin or Knox Nutrajoint.
Likewise, the researchers will not know which group you are in until the end o f
the study.
Knox Nutrajoint - 40 Calories

Maltodextrin - 40 Calories

lOg Gelatin (protein)
300mg Calcium, 30% RDA
60mg Vitamin C, 100%RDA

lOg Maltodextrin (carbohydrate)
Dietetic Cloud
Artificial Colors
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1. The study will last for 8 consecutive weeks.
2. You will have to complete a 15 minute written questionnaire regarding pain
and function before and after the study as well as maintain a daily written log.
3. Your physician will have to confirm your diagnosis of Osteoarthritis or
degenerative joint disease o f one or both knees by signing a form before you
begin participation in this study.
4. The information you provide throughout the course of this study will remain
confidential to the extent permitted by law. Dan Scheffer and Anna Power are the
only people allowed access to the data pertinent to this study. Your identity will
not be disclosed without written consent in any publications resulting firom this
research project.
5. You may experience a decrease in knee pain during the 8-week study.
6. A very small percent%e o f people have experienced minor gastrointestinal
discomfort (gas, bloating) with the consumption o f gelatin due to it’s protein.
7. By participating in this study there is a possibility that the knee pain may
increase temporarily if you are assigned to one o f the exercise groups.
8. The results of this study will be made available to you at the end o f the study
through a mailing.
9. During this study we ask that you not add glucosamine sulfate, chondroitin
sulfate to your diet or change your nonnal eating habits.
10. You are one o f at least 100 volunteers participating in this study.
11 .Knox Nutrajoint and Maltodextrin as well as other nutritional supplementation
are available at any grocery store if you wish to try these instead o f participating
in this study.
12. Participation in this study is voluntary and you may withdraw a t anytime
without any repercussions by contacting either Dan Scheffer or Anna Power by
phone at 1-800-797-6046.
13. If the researchers feel it necessary for you to discontinue with the program
they may do so without your consent. Reasons for discontinuation may include,
but are not limited to, gastrointestinal discomfort with Nutrajoint or excessive
pain with exercise.
14. You will be informed if significant new findings become available, during this
study, that may affect your willingness to continue to participate in this study.
15. A copy of the signed consent form will be given to you.
16. If you are a woman o f child bearing age or think that you are pregnant, you
should consult with you physician prior to entering this study.
17. You will be phoned at weeks 1,4, and 8 o f the study to ask if you have any
questions as you will be going through the program independently.
Please Initial
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I acknowledge that:
A researcher has personally gone over this consent form with me and
given me the opportunity to ask questions about this research study. I also feel
that my questions have been answered to my satisfaction. If I have any questions
during the study I can phone Dan Scheffer at 1-800-797-6046 or Robert
Henderson, chair of H um an Subjects review Board a t G rand Valley State
University a t (616) 895-2195.
I hereby authorize the researchers to release the information obtained in this
study to scientific literature. I have been informed that my name will not be
identified and that all information that I have provided will remain confidential.
I acknowledge that I have read and understand the above information and that I
agree to participate in this study.

(Participant Signature)

Date

(Wimess)

Date
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Appendix G
Physicians Confirm ed Diagnosis

Dear Dr.
I _______________ give Dr._____________ permission to release
information
(patient’s signature)
(print )
from my medical records pertaining the diagnosis o f Osteoarthritis/Degenerative
Joint Disease for the purpose o f research.
I am currently involved in a study on Osteoarthritis with graduate students
and faculty from the Grand Valley State University Physical Therapy program.
In order to participate in this study I m ust have your confirmation that I
have Osteoarthritis/ Degenerative Joint Disease of one o r both knees. Could
you please confirm my diagnosis and send this letter back to the researchers
in the stamped envelope th at I have provided. This study will last for eight
weeks and will look at the effect o f a progressive walking program and Nabisco’s
Knox Nutrajoint on the symptoms of Osteoarthritis. Knox Nutrajoint can be
purchased at any large food store and contains 10 grams of gelatin (protein).
Calcium, and Vitamin C. Maltodextrin will also be used as a carbohydrate
supplement containing com starch and artificial colors. The data will be collected
with the Arthritis Impact Measurement Scale 2 taken both before and after the 8week protocol. 1 will be randomly assigned to one o f four groups. Group one will
walk for up to 30 minutes 3 times per week and consume Knox Nutrajoint. Group
two will only consume Knox Nutrajoint. Group three will walk for up to 30
minutes 3 times per week and consume maltodextrin. Group four will only
consume maltodextrin. The maltodextrin and Knox Nutrajoint will be in powder
form and mixed into a fruit juice for consumption once a day. Thank you for your
time.
I________________ confirm th at________________ was diagnosed with
Osteoarthritis
(Physician’s Signature)

(Patient’s Name)

o f his or her____________ knee(s).

D ate_________

(Left, Right 3oth)

If the Doctor has any questions please feel free to call the researchers:
Dan Scheffer 1-800-797-6046
or Robert Hendersen, chair o f GVSU Human Subjects Review Board at (616)
895-2195
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Appendix H
Instruction sheet for group 1 and 3
1. Fill out and sign the letter to you doctor requesting your diagnosis of
Osteoarthritis or Degenerative Joint Disease.
2. Put the doctor’s letter in the large yellow envelope along with the stamped
envelope addressed to Dan Scheffer marked “Doctor” on the back.
3. Every day you will be mixing one pouch of the powder given to you into at
least 8 ounces o f your favorite juice drink. It is important that you consume this
think 15 minutes to an hour before you exercise.
4. It is important to walk for the designated amount o f time three times a week.
Use the table to determine how long you need to walk each week. Try to walk
Monday, Wednesday and Friday or Tuesday, Thursday, and Saturday. This way
your body will get a day o f rest between exercise.
U o f days a wk*

Week #

1
2
3
4
5
6
7
8

3
3
3
3
3
3
3
3

walking time (minutes)

15
20
25
30
30
30
30
30

*the three weekly walking sessions should be spread out through the week

5. Evciy day fill out your logbook.
6. At the end o f 8 weeks immediately fill out the Arthritis Impact Measurement
Scale 2 **Please make sure that every question is answered, even if it does not
seem to apply to your condition.
1. After completing the Arthritis Impact Measurement Scale 2 put it in the large
stamped envelope marked “DONE” and mail.
8. If you run out o f powder or you have and questions please call Dan Scheffer at
1-800-797-6046.
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Instruction Sheet for Groups 2 and 4

1. Fill out and sign the letter to you doctor requesting your diagnosis of
Osteoarthritis or Degenerative Joint Disease.
2. Put the doctor’s letter in the large yellow envelope along with the stamped
envelope addressed to Dan Scheffer marked “Doctor” on the back.
3. Every day you will be mixing one pouch o f the powder given to you into at
least 8 ounces o f your favorite juice drink. Try to drink this mixture in the
morning.
4. Every day fill out your logbook.
5. At the end of 8 weeks immediately fill out the Arthritis Impact Measurement
Scale 2
**Please make sure that every question is answered^ even if it does not seem to
apply to your condition,
6. After completing the Arthritis Impact Measurement Scale 2 put it in the large
stamped envelope marked “DONE” and mail.
7. If you run out of powder or you have and questions please call Dan Scheffer at
1-800-797-6046
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A ppendix I
Research Assistant instructions

Phone calls to Subjects
1. E a c h s u b j e c t is t o b e c a l l e d a t w e e k s 1, 4 , a n d 8.
2 . I n t r o d u c e y o u r s e l f a s a n a s s i s t a n t i n t h e a r t h r i t i s s tu d y .
3 . A s k th e s u b je c t i f th e y w e re m ix in g th e ir p o w d e re d s u p p le m e n t
in to a liq u id a n d d rin k in g it o n c e p e r d a y .
3 a . I f th e s u b je c t w a s in a n e x e r c is e g ro u p , a s k h o w o fte n th e y w e re
w a lk in g .
4 . A s k e d i f t h e r e a r e a n y q u e s t i o n s o r p r o b l e m s th a t n e e d e d t o b e
a d d re sse d .
5 . T h a n k e a c h s u b j e c t f o r p a r t i c i p a t i n g i n t h e s tu d y .
6 . I f th e s u b je c ts h a v e q u e s tio n s , c o n ta c te d th e p rim a ry r e s e a r c h e r s
D S a n d A P . D S o r A P w ill c a ll th e s u b je c t a n d a n s w e r a n y q u e s tio n s
a n d o r m a il th e s u b je c t a d d itio n a l s u p p le m e n ts i f n e e d e d .
W eek 4
1. F o l l o w a b o v e s t e p s 1 -6
2 . R e m in d s u b je c t to m a il in th e ir c o n f ir m a tio n o f a d ia g n o s is o f
o s te o a r th r itis i f th e y h a d n o t a lr e a d y d o n e s o .
W eeks
1. R e m i n d s u b je c t s t o i n c l u d e t h e i r l o g s h e e t s a n d A I M S 2 s u r v e y s in
th e e n v e lo p e th a t th e y m a il b a c k to th e p rim a ry re s e a rc h e rs.

Note: After the log sheets and the tests were received in the mail
each subject was called by an unblinded research assistant CS. CS
called each subject and revealed which nutritional supplementation
group they were in. Each subject was then thanked again fo r
participating in the research study.
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